Sven Olek

USPTO Granted Patents = 27 (Patent Applications = 6)

CIPO Patents = 10 (Patent Applications = 14)

EPO Patents = 24 (Patent Applications = 31)

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Boothstrasse, DE (2019)
Berlin, DE (2012 - 2024)

Company Filing History:

14 out of 14

Precision for Medicine Gmbh

Leland Stanford Junior University

patents

4. 1 out of 49

Charité – Universitätsmedizin Berlin

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12305237 - CXCR3 as epigenetic marker for the identification of inflammatory immune cells, in particular CD8+ memory t cells (2025-05-20),

2. 12286675 - Epigenetic markers for the identification of blood sub-cells of type 1 (2025-04-29),

3. 12247258 - Epigenetic method to detect and distinguish IPEX and IPEX-like syndromes, in particular in newborns (2025-03-11),

4. 12006546 - Method for epigenetic immune cell detection and counting in human blood samples (2024-06-11),

5. 11976327 - ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs) (2024-05-07),

6. 11788141 - MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells (2023-10-17),

7. 11761041 - PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes (2023-09-19),

8. 11753683 - MCC as epigenetic marker for the identification of immune cells, in particular basophil granulocytes (2023-09-12),

9. 11725243 - Epigenetic method for the identification of follicular T-helper-(TFH-) cells (2023-08-15),

10. 11680294 - Amplicon region as epigenetic marker for the identification of non-classical monocytes (2023-06-20),

11. 11667973 - Endosialin (CD248) as epigenetic marker for the identification of immune cells, in particular naïve CD8+ t-cells (2023-06-06),

12. 11643687 - LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells (2023-05-09),

13. 11597975 - PDCD1 as epigenetic marker for the identification of immune cells, in particular PD1+ cells (2023-03-07),

14. 11319581 - Method for epigenetic immune cell counting (2022-05-03),

15. 10894984 - Method for identifying the quantitative cellular composition in a biological sample (2021-01-19),

Title: The Innovative Journey of Sven Olek

Introduction: Sven Olek, a visionary inventor hailing from Berlin, DE, has made significant contributions to the world of technology and innovation through his groundbreaking ideas and inventions.

Latest Patents: Sven Olek's latest patents focus on renewable energy solutions, sustainable transportation, and advanced materials for construction, showcasing his commitment to creating a more eco-friendly future.

Career Highlights: With a career spanning over two decades, Sven Olek has established himself as a leading figure in the field of clean technology, holding multiple patents and receiving recognition for his innovative approach to solving complex challenges.

Collaborations: Throughout his career, Sven Olek has collaborated with top research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and sustainability in the industry.

Conclusion: Sven Olek's passion for innovation and dedication to creating a more sustainable world have solidified his reputation as a pioneering inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.